The podcast discusses the development of a real-time live tissue sensitivity assay for pancreatic adenocarcinoma, focusing on predicting patients' response to chemotherapy using fresh tumor samples. It highlights the potential for personalized treatment strategies and improved disease-free survival with sensitive adjuvant regimens.